快速连接 发送消息
祝贺瑞迪博士的API（原料药）团队在2019年11月5日于法兰克福举行的2019年全球仿制药和生物仿制药奖上获得年度原料药供应商奖。 th 2019年11月5日. The award acknowledged Dr. Reddy’s API team for its proactive approach in addressing the Sartan issue. 很高兴看到我们团队的努力得到认可。
全球仿制药和生物仿制药奖奖励这两个行业的“最佳实践”，并鼓励改进经营方式。
Click here 点击这里阅读关于瑞迪博士如何解决沙坦需求的白皮书。
No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.
+91 4049002253